AstraZeneca says experimental obesity pill safe in early-stage trial
AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, ...
New Atlas1d
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Khaleej Times6d
New obesity pill is safe and tolerable in early stage trial: AstraZeneca
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
Reuters6d
AstraZeneca says experimental obesity pill safe in early-stage trial
LONDON, Nov 4 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and ...
GMA Network6d
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...
AstraZeneca's Obesity Pills Revealed Positive Result In Phase I Trials
In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...
manilatimes12d
AstraZeneca Indonesia Recognized as the Best Places to Work for Three Consecutive Years
Based on the survey conducted, AstraZeneca Indonesia managed to achieve certification as the Best Place to Work with a total ...
AstraZeneca Says Obesity Pill Well-Tolerated and Competitive
AstraZeneca Plc said its experimental obesity pill was well-tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines.